Critical Contrast: Vapor (OTCMKTS:HCMC) versus West Pharmaceutical Services (NYSE:WST)

Vapor (OTCMKTS:HCMC) and West Pharmaceutical Services (NYSE:WST) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, institutional ownership, risk, earnings and analyst recommendations.

Profitability

This table compares Vapor and West Pharmaceutical Services’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Vapor	N/A	N/A	-452.48%
West Pharmaceutical Services	16.06%	17.90%	13.29%

Analyst Recommendations

This is a summary of current ratings for Vapor and West Pharmaceutical Services, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vapor	0	0	0	0	0.00
West Pharmaceutical Services	0	4	7	1	2.75

West Pharmaceutical Services has a consensus target price of $315.67, indicating a potential upside of 2.08%. Given West Pharmaceutical Services’ stronger consensus rating and higher possible upside, analysts plainly believe West Pharmaceutical Services is more favorable than Vapor.

Earnings & Valuation

This table compares Vapor and West Pharmaceutical Services”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vapor	N/A	N/A	-$7.02 million	N/A	N/A
West Pharmaceutical Services	$3.07 billion	7.25	$493.70 million	$6.79	45.54

West Pharmaceutical Services has higher revenue and earnings than Vapor.

Insider and Institutional Ownership

0.1% of Vapor shares are owned by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are owned by institutional investors. 44.9% of Vapor shares are owned by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Risk & Volatility

Vapor has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500. Comparatively, West Pharmaceutical Services has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500.

Summary

West Pharmaceutical Services beats Vapor on 11 of the 12 factors compared between the two stocks.

About Vapor

Healthier Choices Management Corp. operates natural and organic retail stores in the United States. The company operates in two segments, Grocery and Vapor. The company operates Ada's Natural Market and Paradise Health & Nutrition stores that offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health and beauty products, and natural household items; Mother Earth's Storehouse and Ellwood Thompson stores, which provide organic and health foods, and vitamins; and Greens Natural Food stores that offers organic produce and non-GMO groceries and bulk foods, various local products, juice and smoothie bar, fresh foods, vitamins and supplements, and health and beauty products. It also sells vitamins and supplements, as well as health, beauty, and personal care products through its TheVitaminStore.com website. In addition, the company offers Q-Unit and Q-Cup technology, a product that enables consumers to vape concentrates either medicinally or recreationally. Healthier Choices Management Corp. is headquartered in Hollywood, Florida.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.